Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02795767
Brief Title: A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors (HAVEN 2)

First Submitted : June 7, 2016
First Submitted that Met QC Criteria : June 7, 2016
First Posted : June 10, 2016 (Estimate)

Results First Submitted : March 20, 2019
Results First Submitted that Met QC Criteria : March 20, 2019
Results First Posted : April 10, 2019

Last Update Submitted that Met QC Criteria : May 7, 2021
Last Update Posted : June 2, 2021